Profile data is unavailable for this security.
About the company
Medicamen Biotech Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing pharmaceutical formulations products. The Company manufactures a range of products, including tablets, capsules, liquid syrup, dry syrup, such as beta-lactum and non-beta lactum, and ointments. The Company is primarily focused on oncology therapeutics. The Company is also focused on other therapeutic areas, such as cardiology, central nervous system (CNS), diabetology and pain management. The Company's oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Lenalidomide, Letrozole, Melphalan, Nilotinib HCI, Oxaliplatin, Pazopanib, Pomalidomide and Tegafur. The Company has two manufacturing plants at Bhiwadi (Rajasthan) and Haridwar (Uttarakhand). The Company's wholly owned subsidiary is OPAL Pharmaceuticals Pty Ltd.
- Revenue in INR (TTM)1.25bn
- Net income in INR137.00m
- Incorporated1993
- Employees357.00
- LocationMedicamen Biotech Ltd1506, Chiranjiv Tower, 43, Nehru PlaceNEW DELHI 110019IndiaIND
- Phone+91 1 147589500
- Fax+91 1 126213081
- Websitehttp://www.medicamen.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Windlas Biotech Ltd | 4.95bn | 459.70m | 5.07bn | 962.00 | 11.36 | -- | 8.78 | 1.02 | 21.13 | 21.13 | 227.25 | -- | -- | -- | -- | 5,140,343.00 | -- | -- | -- | -- | 36.09 | -- | 9.30 | -- | -- | 50.42 | -- | -- | 8.96 | -- | 140.58 | -- | -- | -- |
| Kopran Ltd | 5.43bn | 367.07m | 5.12bn | 400.00 | 13.84 | -- | 10.49 | 0.9431 | 7.68 | 7.68 | 113.36 | -- | -- | -- | -- | 13,585,460.00 | -- | 9.73 | -- | 15.45 | 36.52 | 36.60 | 6.75 | 9.40 | -- | 4.01 | -- | -- | -2.91 | 8.42 | -0.9334 | 25.11 | 21.27 | -- |
| SMS Pharmaceuticals Ltd | 4.34bn | -41.61m | 5.46bn | 1.03k | -- | -- | 14.54 | 1.26 | -0.4871 | -0.4871 | 51.05 | -- | -- | -- | -- | 4,205,091.00 | -- | 7.71 | -- | 10.22 | 22.94 | 34.08 | 1.25 | 10.04 | -- | -0.227 | -- | 5.01 | -7.69 | 3.08 | -0.491 | 16.91 | 3.26 | 8.45 |
| Syncom Formulations India Ltd | 2.22bn | 163.62m | 5.64bn | -- | 29.46 | -- | 27.19 | 2.55 | 0.2037 | 0.2037 | 2.65 | -- | -- | -- | -- | -- | -- | 7.84 | -- | 10.43 | 36.15 | 31.24 | 7.39 | 8.17 | -- | 4.10 | -- | -- | -10.27 | 3.51 | -32.16 | 13.19 | 7.58 | 8.45 |
| Beta Drugs Ltd | -100.00bn | -100.00bn | 6.06bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.91 | -- | 356.78 | -- | -- | -- |
| Lincoln Pharmaceuticals Ltd | 5.00bn | 713.61m | 6.61bn | 1.25k | 9.27 | -- | 8.25 | 1.32 | 35.62 | 35.62 | 249.77 | -- | -- | -- | -- | -- | -- | 13.45 | -- | 17.08 | 52.37 | 50.55 | 14.26 | 13.25 | -- | 56.07 | -- | -- | 11.30 | 5.26 | 11.46 | 19.79 | 20.91 | 4.56 |
| Vimta Labs Ltd | 3.00bn | 487.64m | 6.65bn | 1.27k | 13.88 | 2.58 | 8.77 | 2.21 | 21.65 | 21.65 | 133.37 | 116.38 | 0.9588 | 3.90 | 3.89 | 2,359,890.00 | 15.56 | 8.88 | 18.82 | 11.18 | 76.17 | 71.34 | 16.23 | 10.45 | 2.27 | 25.64 | 0.0638 | 15.89 | 32.09 | 12.58 | 93.09 | 31.30 | -0.5906 | -- |
| Medico Remedies Ltd | -100.00bn | -100.00bn | 6.68bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.41 | -- | 7.20 | -- | 24.67 | -- | 2.43 | -- | -- | -- | -- | -1.12 | 17.33 | 88.68 | 24.60 | -4.35 | -- |
| Panacea Biotec Ltd | 4.72bn | 12.17bn | 6.96bn | 1.06k | 0.5729 | -- | 0.5671 | 1.48 | 198.47 | 198.47 | 77.11 | -- | -- | -- | -- | 4,458,904.00 | -- | 9.69 | -- | 17.46 | 43.98 | 55.39 | 257.85 | 24.67 | -- | -2.27 | -- | 0.00 | 5.83 | 3.46 | 837.06 | -- | -12.14 | -- |
| Zota Health Care Ltd | 1.34bn | -41.49m | 7.47bn | 297.00 | -- | -- | 135.59 | 5.56 | -1.65 | -1.65 | 53.61 | -- | -- | -- | -- | 4,526,751.00 | -- | 5.37 | -- | 7.05 | 36.48 | 30.73 | -3.09 | 4.88 | -- | -1.62 | -- | 67.63 | 22.85 | 12.88 | 4,364.05 | 9.96 | 11.07 | 0.9805 |
| Jagsonpal Pharmaceuticals Ltd | 2.25bn | 204.13m | 7.80bn | -- | 38.24 | -- | 35.83 | 3.47 | 7.79 | 7.79 | 85.90 | -- | -- | -- | -- | -- | -- | 5.39 | -- | 6.85 | 60.36 | 58.22 | 9.08 | 4.60 | -- | 98.92 | -- | 38.85 | 15.77 | 8.44 | 10.54 | 9.71 | -28.93 | 109.13 |
| Medicamen Biotech Ltd | 1.25bn | 137.00m | 7.81bn | 357.00 | 56.06 | -- | 39.10 | 6.25 | 11.01 | 11.01 | 100.53 | -- | -- | -- | -- | 3,500,164.00 | -- | 8.02 | -- | 11.97 | 51.22 | 33.66 | 10.97 | 10.62 | -- | 6.12 | -- | 9.01 | 2.42 | 6.96 | 22.82 | 23.62 | 29.99 | 0.00 |
| Bliss GVS Pharma Ltd | 7.34bn | 871.47m | 7.83bn | 750.00 | 9.15 | -- | 6.82 | 1.07 | 8.21 | 8.21 | 69.11 | -- | -- | -- | -- | 9,784,959.00 | -- | 7.11 | -- | 9.87 | 48.31 | 36.87 | 13.18 | 10.68 | -- | 16.38 | -- | 11.79 | 29.50 | 12.91 | -78.04 | -6.36 | -6.52 | -3.58 |
| NGL Fine-Chem Ltd | 2.82bn | -817.29m | 8.26bn | 329.00 | -- | -- | -- | 2.93 | -132.29 | -132.29 | 457.23 | -- | -- | -- | -- | 8,580,666.00 | -- | 17.96 | -- | 24.18 | 13.77 | 48.76 | -28.95 | 14.83 | -- | -63.53 | -- | 2.93 | 23.08 | 24.42 | -12.03 | 27.37 | 22.93 | -- |
| Bajaj Healthcare Ltd | 6.91bn | 569.04m | 9.11bn | 1.05k | 16.02 | -- | 11.24 | 1.32 | 20.62 | 20.62 | 250.20 | -- | -- | -- | -- | 6,564,269.00 | -- | 11.38 | -- | 19.70 | 26.47 | 25.65 | 8.24 | 8.64 | -- | 4.44 | -- | -- | 3.49 | 24.14 | -14.11 | 55.61 | 50.96 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Motilal Oswal Asset Management Co. Ltd.as of 28 Feb 2023 | 52.00 | 0.00% |
